Logo
ASHM
  • Introduction
  • About
  • Acknowledgements
  • Glossary of terms
  • Bookmarks
  • Contact Us
  • Epidemiology & Natural History
    • Epidemiology of HIV infection in Australasia
    • Natural history of HIV infection
  • Virology & Immunology
    • Basic HIV virology
    • HIV immunology
  • Diagnostic & Monitoring Tests
    • Virological tests
    • Immunological tests
  • Primary HIV infection
  • HIV-infectious Disease & Cancer
    • Respiratory tract infections in patients with HIV infection
    • Tuberculosis
    • Non-tuberculous mycobacterial infections in people with HIV infection
    • Opportunistic infections of the gastrointestinal tract
    • Ocular disease in patients with HIV infection
    • Opportunistic infections acquired in localised geographical regions of the world
    • Human papillomavirus-associated malignancy
    • Skin disease
    • Opportunistic infections of the nervous system (coming soon)
    • Malignant and lymphoproliferative conditions complicating HIV infection (coming soon)
    • Opportunistic infections and cancers of the mouth and oropharynx (coming soon)
  • Other HIV-Associated Disease
    • Haematological disorders
    • Heart disease
    • Rheumatological disease
    • Neurological disease (coming soon)
    • Pulmonary disease – incl. sarcoidosis and COPD (coming soon)
  • Co-infections
    • Sexually transmissible infections among people with HIV infection
    • Hepatitis C virus
    • Hepatitis B virus
    • Hepatitis E virus
    • HTLV-1
  • ARV Drugs & other Therapies
    • Antiretroviral drugs
    • Initiation of antiretroviral therapy in treatment-naïve people
    • Long-term management of antiretroviral therapy
    • Antiretroviral therapy guidelines
    • Immune reconstitution inflammatory syndrome and other immune reconstitution disorders
    • Prevention of opportunistic infections with antimicrobial therapy (coming soon)
    • Drug-drug interactions in patients with HIV infection
    • Adverse reactions to antiretroviral and other drugs in people with HIV infection
    • Vaccines in people with HIV infection
  • Co-Morbidities
    • Atherosclerotic vascular disease
    • Endocrine disorders
    • Bone disease in patients with HIV infection
    • Renal disease
  • Special Patient Populations
    • Ageing with HIV infection
    • Psychiatric disorders in people with HIV infection
    • Adolescents transitioning to adult care
    • HIV infection in Aboriginal and Torres Strait Islander people
    • Pregnant women (coming soon)
  • Biomedical prevention
    • PEP and PrEP
    • Microbicides
    • ASHM PrEP guidelines
  • Nurses & Midwives
    • New HIV Diagnosis
    • Late presentation of new HIV diagnosis
    • Partner notification and contact tracing
    • Key Affected Populations
    • Pregnancy and midwifery considerations in HIV
    • Paediatric issues
    • Client education
    • Nursing considerations of major clinical issues
    • HIV-associated neurocognitive disorder
    • Adherence support
    • Health promotion
    • Clinical supervision for nurses in the HIV sector
    • Biomedical HIV prevention
    • Evolving roles of nurses in HIV care
    • Nursing ethics in the care of people with HIV
  • HIV Management for nurses and midwives

References

1. UNAIDS. Early diagnosis and treatment save babies from AIDS-related death. 2009; Geneva: UNAIDS. 
2. UNAIDS, 2019 https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf

  • Paediatric issues
  • Australian models of care
  • Links
  • References

Introduction About Acknowledgements Glossary of terms Bookmarks Copyright Contact Us

© ASHM 2019, ASHM Developing a sustainable HIV, Viral Hepatitis, and Sexual Health Workforce | Privacy policy

  • Epidemiology & Natural History
    • Epidemiology of HIV infection in Australasia
    • Natural history of HIV infection
  • Virology & Immunology
    • Basic HIV virology
    • HIV immunology
  • Diagnostic & Monitoring Tests
    • Virological tests
    • Immunological tests
  • Primary HIV infection
  • HIV-infectious Disease & Cancer
    • Respiratory tract infections in patients with HIV infection
    • Tuberculosis
    • Non-tuberculous mycobacterial infections in people with HIV infection
    • Opportunistic infections of the gastrointestinal tract
    • Ocular disease in patients with HIV infection
    • Opportunistic infections acquired in localised geographical regions of the world
    • Human papillomavirus-associated malignancy
    • Skin disease
    • Opportunistic infections of the nervous system (coming soon)
    • Malignant and lymphoproliferative conditions complicating HIV infection (coming soon)
    • Opportunistic infections and cancers of the mouth and oropharynx (coming soon)
  • Other HIV-Associated Disease
    • Haematological disorders
    • Heart disease
    • Rheumatological disease
    • Neurological disease (coming soon)
    • Pulmonary disease – incl. sarcoidosis and COPD (coming soon)
  • Co-infections
    • Sexually transmissible infections among people with HIV infection
    • Hepatitis C virus
    • Hepatitis B virus
    • Hepatitis E virus
    • HTLV-1
  • ARV Drugs & other Therapies
    • Antiretroviral drugs
    • Initiation of antiretroviral therapy in treatment-naïve people
    • Long-term management of antiretroviral therapy
    • Antiretroviral therapy guidelines
    • Immune reconstitution inflammatory syndrome and other immune reconstitution disorders
    • Prevention of opportunistic infections with antimicrobial therapy (coming soon)
    • Drug-drug interactions in patients with HIV infection
    • Adverse reactions to antiretroviral and other drugs in people with HIV infection
    • Vaccines in people with HIV infection
  • Co-Morbidities
    • Atherosclerotic vascular disease
    • Endocrine disorders
    • Bone disease in patients with HIV infection
    • Renal disease
  • Special Patient Populations
    • Ageing with HIV infection
    • Psychiatric disorders in people with HIV infection
    • Adolescents transitioning to adult care
    • HIV infection in Aboriginal and Torres Strait Islander people
    • Pregnant women (coming soon)
  • Biomedical prevention
    • PEP and PrEP
    • Microbicides
    • ASHM PrEP guidelines
  • Nurses & Midwives
    • New HIV Diagnosis
    • Late presentation of new HIV diagnosis
    • Partner notification and contact tracing
    • Key Affected Populations
    • Pregnancy and midwifery considerations in HIV
    • Paediatric issues
    • Client education
    • Nursing considerations of major clinical issues
    • HIV-associated neurocognitive disorder
    • Adherence support
    • Health promotion
    • Clinical supervision for nurses in the HIV sector
    • Biomedical HIV prevention
    • Evolving roles of nurses in HIV care
    • Nursing ethics in the care of people with HIV